Health & Nutrition
Eli Lilly says obesity drug tirzepatide resulted in weight...
Eli Lilly plans to complete its application for FDA approval of tirzepatide in the...
Merck results beat expectations despite a big drop in sales...
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for...
Alzheimer's: Medicare will cover Leqembi for all patients...
Medicare has severely restricted access to the medication Leqembi, which costs $26,500...
No prison yet for Elizabeth Holmes following last-ditch...
Theranos founder Elizabeth Holmes has appealed a judge's ruling that she report...
Eli Lilly misses on earnings but raises full-year guidance
The company reported adjusted earnings of $1.62, which missed analyst expectations...
Dr. Greger’s Top Takeaways on Dietary Cholesterol, Fasting...
Every month, we publish around eight new videos, four Friday Favorites, eight blogs,...
Biogen isn't concerned about competing with Eli Lilly in...
Biogen CEO Christopher Viehbacher said during an earnings call that Eli Lilly needs...
FDA grants accelerated approval for Biogen ALS drug that...
The FDA's approval requires Biogen to further study its ALS drug tofersen to further...
Illumina unveils plans to cut costs as it faces shrinking...
The plans aim to reduce Illumina's annualized run rate expenses by more than $100...
Mpox outbreak was wake-up call for smallpox preparation,...
Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare...
